Company Filing History:
Years Active: 2007-2017
Title: David Charles Muchmore: Innovator in Pharmaceutical Chemistry
Introduction
David Charles Muchmore is a notable inventor based in Eugene, OR (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target persistent sodium currents. With a total of 3 patents to his name, Muchmore's work has the potential to impact the treatment of various medical conditions.
Latest Patents
Muchmore's latest patents include innovative compounds that serve as selective blockers of persistent sodium current. One of his key inventions is directed to a compound of Formula I or a pharmaceutically acceptable salt thereof. This invention aims to provide pharmaceutical compositions that can treat diseases or conditions mediated by elevated persistent sodium current, such as ocular disorders, multiple sclerosis, seizure disorders, and chronic pain.
Career Highlights
David Charles Muchmore is currently associated with Allergan, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options for patients suffering from complex medical conditions.
Collaborations
Muchmore has collaborated with esteemed colleagues in his field, including Alfred Arthur Avey, Jr. and Lloyd Jay Dolby. These collaborations have further enriched his research and contributed to the success of his innovative projects.
Conclusion
David Charles Muchmore stands out as a dedicated inventor whose work in pharmaceutical chemistry is paving the way for new treatment options. His contributions are vital in addressing significant health challenges, and his ongoing research promises to yield further advancements in the field.